Fatigue That Doesn't Resolve With Rest Is a Cellular Energy Problem

What Is Chronic Fatigue?

Chronic fatigue is not the same as being tired. Normal tiredness is proportionate to activity and resolves with rest. Chronic fatigue is disproportionate to what you have done, does not lift with sleep, and often gets worse after mild exertion rather than better. That last pattern, called post-exertional malaise, is the signature of cellular energy production failure, not a need for more rest.

The primary driver in most chronic fatigue presentations is mitochondrial dysfunction. Mitochondria produce approximately 95% of cellular energy, and when they are impaired by NAD+ depletion, CoQ10 deficiency, oxidative damage, or the chronic inflammatory environment that suppresses mitochondrial biogenesis, ATP output falls. The body cannot meet even modest energy demands.

Secondary contributors include HPA axis dysregulation, where cortisol curves flatten and the morning energy signal weakens; cellular thyroid resistance, where T4-to-T3 conversion is impaired even when TSH is technically normal; and gut-energy axis disruption, where microbiome changes reduce short-chain fatty acid production and increase the systemic inflammatory load suppressing mitochondrial recovery.

Who the Fatigue Protocol Is For

This protocol is built for patients who are dealing with one or more of the following:

• Fatigue that persists despite adequate sleep and has not responded to rest, diet changes, or conventional treatment
• Post-exertional malaise where mild activity produces exhaustion that takes days to recover from
• Morning fatigue, afternoon energy crashes, or difficulty sustaining mental or physical effort throughout the day
• Lab work that comes back normal while the experience of daily exhaustion remains real and limiting

How the Fatigue Protocol Works

Every patient begins with a baseline panel measuring the specific markers relevant to fatigue biology, including NAD+ status, CoQ10, inflammatory cytokines, free T3 and reverse T3, adrenal function, and mitochondrial markers. The protocol then moves through three stages, each building on the last.

What the Protocol May Include: oral NAD+ precursors (NMN or nicotinamide riboside), CoQ10 and magnesium glycinate for mitochondrial energy production, omega-3 fatty acids for mitochondrial membrane repair, and targeted gut support. As the protocol advances, injectable vitamins at the clinic deliver therapeutic levels of NAD, B-complex, carnitine, CoQ10, and magnesium that oral supplementation cannot match. For appropriate patients, Stage 3 adds peptide therapy, including MOTS-c, a mitochondrial-derived peptide that directly improves cellular energy efficiency, and BPC-157 for gut-energy axis repair.

Stage 1 (Pathway) is the most accessible entry point, focused on foundational supplementation and lifestyle interventions that produce meaningful improvement in energy for many patients within four to six weeks. Stage 2 (Roadmap) adds injectable vitamin delivery at the clinic, achieving therapeutic plasma levels that bypass gut absorption limitations and accelerate the cellular energy restoration Stage 1 began. Stage 3 (Atlas) is the full protocol, reserved for complex or refractory presentations, adding evidence-backed peptides and, where appropriate, growth hormone secretagogue therapy to optimize the overnight repair signal that mitochondrial recovery depends on.